Delivery Order SPE2DR25D3102-SPE2DR26F2Q2H
- Not listed
- AmerisourceBergen Drug Corp has been awarded a $9,024 delivery order for M-M-R II vaccine vials by the Defense Logistics Agency (DLA), with a final completion date of December 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement valued through December 2026 that enables...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for M-M-R II vaccine vials valued at $3,269.25 on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was issued under a competitively awarded, non-set-aside procurement by the Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. The contract represents...
- The Defense Logistics Agency awarded a delivery order valued at $3,034.01 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction supporting federal medical supply needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $34,811.78 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 29, 2025, with completion scheduled for September 2, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The vaccine delivery will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $31,839.65 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 7, 2026, with a completion date of January 8, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving critical federal medical...
- The Defense Logistics Agency awarded a $1,039.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 10, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,141.87 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of December 18, 2025. This non-competitive delivery order represents a firm fixed price procurement to support federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,119.10 by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationship with DLA. The award carries no set-aside designation and will be performed at the vendor's corporate office...
- Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide M-M-R II vaccine vials. The $5,550.74 order has a completion date of February 13, 2024 and was awarded on February 12, 2024. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that enables Amerisourcebergen to deliver a range of pharmaceutical products and medical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,119.10 by the Defense Logistics Agency (DLA) on August 11, 2025, with an ultimate completion date of August 12, 2025. The delivery order is for M-M-R II vaccine vials to be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, non-set-aside contract awarded through open competition, structured as a child contract under a larger vehicle. AmerisourceBergen Drug Corp, a...
- SPE2DR25D3102Indefinite Delivery Contract
- SPE2DR25D3102-SPE2DR26F2Q2HDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a $4,375.38 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on January 7, 2026, for M-M-R II vaccine vials. The contract is a non-set-aside award with an ultimate completion date of January 8, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in supplying medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company's ability to fulfill this vaccine order reflects its extensive experience in delivering pharmaceutical products across multiple therapeutic domains through competitively awarded contracts. The DLA Medical Supply Chain relies on vendors like Amerisourcebergen to ensure the availability of essential medical commodities, including vaccines, to support Defense Health Agency operations and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 1/6/26 |